MAPS Public Benefit Corp. closed a $100 million Series A funding round and rebranded as Lykos Therapeutics, the company announced Thursday. The funding, which will support the company’s development of MDMA-assisted therapy for post-traumatic stress disorder, comes from a range of new investors, alongside the conversion of an undisclosed sum …
Functional mushrooms have seen a significant spike in interest since last summer, a development that analysts say is a result of rising interest for natural health products in general. According to a recent Brightfield Group report, these mushrooms, which are believed to help the body manage stress, used to be …
The Daily Hit is a recap of the top financial news stories for Jan. 4, 2024. On the Site California Cannabis Company Sues State, Alleges ‘Massive Overcollection’ of Taxes HNHPC Inc. – which is a wing of Long Beach-based Catalyst Cannabis Co. – has filed suit against several state agencies, …